No Data
No Data
Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)
Telix Pharmaceuticals Price Target Raised 7.1% to A$33.10/Share by Jefferies
Telix Pharmaceuticals Price Target Raised 7.1% to A$33.10/Share by
Buy This High-flying ASX Healthcare Stock for Market-beating Returns
The ASX healthcare stock in this article has been on fire over the past 12 months.
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
AU Morning Wrap: ASX Falls, Domino's Drops, Accent to Close Glue Stores
Australian shares fell 0.2 per cent at the open as the tech sector tumbled 1.7 per cent to follow its overseas peers lower.
Telix Share Price Hits Record High on Strong Quarter and Guidance Upgrade
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is rising again on Thursday morning.
No Data
102243279 : K